| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 5.86 mm | 17.82 mm | (no burn) | 3.33 mm |
| Cash used (since last report) | n/a | n/a | 28.20 mm | 85.79 mm | n/a | 16.03 mm |
| Cash remaining | n/a | n/a | 192.66 mm | 135.08 mm | n/a | 204.84 mm |
| Runway (months of cash) | n/a | n/a | 32.9 | 7.6 | n/a | 61.5 |
| 13F holders | Current |
|---|---|
| Total holders | 74 |
| Opened positions | 15 |
| Closed positions | 13 |
| Increased positions | 31 |
| Reduced positions | 9 |
| 13F shares | Current |
|---|---|
| Total value | 119.15 bn |
| Total shares | 19.19 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Murat Kalayoglu | 4.56 mm | $93.43 mm |
| Mangrove Partners Master Fund | 3.33 mm | $10.10 mm |
| FMR | 2.42 mm | $43.40 bn |
| Biotechnology Value Fund L P | 1.72 mm | $0.00 |
| Vivo Capital IX | 1.37 mm | $4.00 mm |
| MPM Oncology Impact Management | 721.14 k | $12.92 bn |
| BlackRock | 659.40 k | $11.81 bn |
| Artal International S.C.A. | 594.94 k | $0.00 |
| Siren, L.L.C. | 572.24 k | $10.25 bn |
| Timothy A Springer | 563.21 k | $10.86 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jan 25 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 18 | 4,022 | 72.40 k | 8,531,462 |
| 13 Jan 25 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 17.7822 | 8,983 | 159.74 k | 8,527,440 |
| 13 Jan 25 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 16.8576 | 7,962 | 134.22 k | 8,518,457 |
| 10 Jan 25 | Christopher M Jewell | Common Stock | Option exercise | Acquire M | No | No | 3.23 | 9,000 | 29.07 k | 62,490 |
| 10 Jan 25 | Christopher M Jewell | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.23 | 9,000 | 29.07 k | 67,432 |
| 6 Jan 25 | Emily English | Common Stock | Sell | Dispose S | No | No | 16.8322 | 906 | 15.25 k | 40,226 |
| 6 Jan 25 | Milos Miljkovic | Common Stock | Sell | Dispose S | No | No | 16.8322 | 948 | 15.96 k | 35,393 |
| 6 Jan 25 | Christopher M Jewell | Common Stock | Sell | Dispose S | No | No | 16.8322 | 1,286 | 21.65 k | 53,490 |
| 3 Jan 25 | Emily English | Common Stock | Sell | Dispose S | No | No | 16.7219 | 891 | 14.90 k | 41,132 |
| 3 Jan 25 | Milos Miljkovic | Common Stock | Sell | Dispose S | No | No | 16.7219 | 932 | 15.58 k | 36,341 |
